Weisblum Eric
Silo Pharma, Inc. · Chief Executive Officer
Weisblum Eric is listed in filings as Chief Executive Officer at Silo Pharma, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including purchase activity. Recent filings connect the profile to Silo Pharma, Inc. (SILO). The current snapshot covers public activity from Jun 13, 2024 to Dec 16, 2025. Reported amounts are shown as $1.1K to $365. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3651k shares | BuyNov 21, 2025 | $0.365 | $6.12 | |
| $3701k shares | BuyNov 20, 2025 | $0.37 | $6.12 | |
| $1.8k4.5k shares | BuyNov 19, 2025 | $0.405 | $6.12 | |
| $3.0k7.5k shares | BuyNov 18, 2025 | $0.4033 | $6.12 | |
| $4.3k10k shares | BuyMay 27, 2025 | $0.4329 | $6.12 | |
| $2.1k2.5k shares | BuyDec 13, 2024 | $0.8387 | $6.12 | |
| $2.3k2.5k shares | BuyNov 22, 2024 | $0.90 | $6.12 | |
| $2.4k2.5k shares | BuyNov 20, 2024 | $0.95 | $6.12 | |
| $4.9k4.4k shares | BuyJun 12, 2024 | $1.11 | $6.12 | |
| $607562 shares | BuyJun 11, 2024 | $1.08 | $6.12 |